The U.S. should do more to combat counterfeit medicines and protect intellectual property rights, said Jeffrey Kindler, the chief executive officer of Pfizer Inc., the world's largest drugmaker.

Seizures of bogus prescription medicines jumped 24 percent to 1,513 incidents in 2007, and illicit versions of 403 different prescription drugs were confiscated in 99 countries, according to the Pharmaceutical Security Institute, a Vienna, Virginia group funded by 26 drugmakers.

Source: Bloomberg

View Full Article